- Home
- PUSA vs DXR Comparison
PUSA vs DXR Comparison
Compare PUSA & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PUSA | DXR |
|---|---|---|
| Founded | N/A | 1970 |
| Country | United States | United States |
| Employees | 47 | N/A |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.6M | 59.0M |
| IPO Year | 2025 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PUSA | DXR |
|---|---|---|
| Price | $2.98 | $10.53 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 298.9K | 1.6K |
| Earning Date | N/A | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.65 | $8.56 |
| 52 Week High | $4.45 | $14.76 |
Technical Indicators
Market Signals| Indicator | PUSA | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 22.21 | 51.43 |
| Support Level | N/A | $9.79 |
| Resistance Level | $3.90 | $10.91 |
| Average True Range (ATR) | 0.27 | 0.40 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 10.00 | 22.58 |
Price Performance
Historical ComparisonAbout PUSA Aureus Greenway Holdings Inc. Common Stock
Aureus Greenway Holdings Inc own and operate two public golf country clubs in Florida. The golf country clubs include two golf-courses with over 13,000 yards of combined fairways, clubhouses boasting food and beverage options, aquatic golf ranges, and pro shops to assist any level of golfer and also host local golf leagues, golf-tournaments, and private events. Its golf country clubs is organized into four principal business segments: (i) golf recreation, retail golf products, and equipment and facilities rental, (ii) membership dues, (iii) food and beverage services. and (iv) ancillary services and amenities. All assets of the Company are located in Florida and all revenue is generated from Florida.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.